News

Researchers have shown that a tiny nanoparticle formulation of saponin, along with an inflammation-promoting molecule called MPLA, can be used as an adjuvant for an HIV vaccine under trial. An alum ...
Africa Check has debunked viral social media claims about an HIV “cure”, clarifying that the breakthrough is promising, but ...
Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that just a single dose can provide strong protection from HIV.
Kennedy testified before the House Energy and Commerce Health Subcommittee about health spending cuts and health agency ...
A supercharged HIV vaccine could offer strong protection with just one injection, a study in mice has indicated. Developed by researchers from the Massachusetts Institute of Technology (MIT) and the ...
Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...
Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...
Immuno Cure BioTech and PharmaJet are working together on a clinical study to test the effectiveness of PharmaJet’s needle-free vaccine delivery system for Immuno Cure’s HIV therapeutic DNA vaccine. 1 ...
GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...
A line from Trump’s speech to Congress had ripple effects on health research funding for everything from HIV to asthma to ...